Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • ZoeG
    Member
    • Jun 2013
    • 31

    #1

    mtRNA expression distribution in RNASeq

    Hey, Any one experienced in mtRNA (mitochondrial RNA) expression?

    I mapped my data to mtRNA and found that the counts of protein-coding RNA are much higher than that of tRNA and rRNA (hundreds or thousands fold).

    Is this a normal mitochondrial RNA distribution?
    Thanks
  • dpryan
    Devon Ryan
    • Jul 2011
    • 3478

    #2
    That kind of depends on the species, tissue, and methods used to extract the RNA and make the library, doesn't it?

    Comment

    • sara_ahmed
      Member
      • Nov 2011
      • 13

      #3
      Agree with dpryan. It depends on all of those things. Were these prepared after polyA selection? That tends to have the highest mtRNA carry through because of polyA tails on mtRNA. The levels can fluctuate between cell types but its not uncommon to see higher levels of mtRNA compared to rRNA reads.

      Sara Ahmed, PhD | Director of Sequencing | Cofactor Genomics
      3141 Olive St. | St. Louis, MO 63103 | tel. (314) 531-4647

      Comment

      • ZoeG
        Member
        • Jun 2013
        • 31

        #4
        Thanks, dpryan, sara.
        The total RNA was extracted using Qiagen RNeasy mini kit from mouse skeletal muscle. The library was prepared following illumina TruSeq sample preparation. I suppose these steps are common for RNA preparation and library preparation.

        The way how I mapped to mtRNA is some tricky.
        I didn't map my data to mtRNA directly.
        Raw data was mapped to a GTF containing chr1~chr19+chrX,Y, but not chrM firstly.
        Thus, genes from chrM were left in the unmapped reads. Then, I mapped unmapped reads to a chrM GTF and got the counts of mitochondrial genes.
        Mapping chrM genes first time, not sure whether these operations will induce bias..
        Comments?

        Comment

        • dpryan
          Devon Ryan
          • Jul 2011
          • 3478

          #5
          Skeletal muscle has a lot of mitochondria, so I'm not surprised that you get an enrichment of that. With the Qiagen kits, remember that the columns themselves do some size filtering, so you'll lose much of the RNA <200nt (namely tRNA, microRNAs, and the smaller rRNAs). Those two alone could yield the results that you see.

          BTW, I would encourage you to include chrM in your reference during alignment. As a general principle, you increase false-positive alignments if you align reads arising from the entire genome to only a subset of the genome. Granted, chrM is pretty small, so that bias is probably not large, but it's simple to just include that in the reference fasta and GTF/GFF.

          Comment

          • ZoeG
            Member
            • Jun 2013
            • 31

            #6
            Thanks, dpryan. I understand that align entire genome reads to a subset of genome will causes false positive outputs, especially mitochondrial genes are relatively small. So I am thinking whether it is okay to align those big genes first and then align unmapped to chrM genes. But you are right, it worths a try to include chrM in the reference.
            Another reason for me to do this is that my raw data seems a little weird. If I align the raw data to whole genome (TopHat -G), it generated tons of 'novel' junctions which is probably not true. I have to add some conditions, for example, align to known genes only. I am not sure whether these conditions will exclude chrM genes, will try soon.

            Comment

            Latest Articles

            Collapse

            • SEQadmin2
              Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
              by SEQadmin2



              Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

              Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
              ...
              10-14-2026, 09:55 AM
            • SEQadmin2
              New Genomics Technologies Take Aim at Long-Standing Limits
              by SEQadmin2


              Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

              We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
              ...
              09-28-2026, 10:25 AM

            ad_right_rmr

            Collapse

            News

            Collapse

            Topics Statistics Last Post
            Started by SEQadmin2, 10-22-2026, 11:13 AM
            0 responses
            30 views
            0 reactions
            Last Post SEQadmin2  
            Started by SEQadmin2, 10-22-2026, 10:48 AM
            0 responses
            22 views
            0 reactions
            Last Post SEQadmin2  
            Started by SEQadmin2, 10-15-2026, 10:52 AM
            0 responses
            39 views
            0 reactions
            Last Post SEQadmin2  
            Started by SEQadmin2, 10-14-2026, 05:39 AM
            0 responses
            45 views
            0 reactions
            Last Post SEQadmin2  
            Working...